Charles Schulz under scrutiny for Seroquel study suicide
"This case goes beyond everything and anything, and this should have brought the house down on the university."
Medical Ethics
"This case goes beyond everything and anything, and this should have brought the house down on the university."
President Obama ordered a review by his bioethics commission following the revelations that yet another experiment sponsored by the U.S. Public Health Service, was even more odious than the infamous Tuskegee Syphilis experiment. In the recently uncovered experiment, unwitting Guatemalans were deliberately infected with syphilis by the same doctor who…
"… it’s appalling — that, at the same time as the United States was prosecuting Nazi doctors for crimes against humanity, the U.S. government was supporting research that placed human subjects at enormous risk.”
Does an "apology" suffice for criminal experimentation designed to cause harm?
"OHRP shared your concerns and discussed them with the National Heart Lung and Blood Institute. They appreciated the concerns and have revised the protocol to address them."
The US government is initiating several radical medical experiments that will ensure widespread, increased use of mostly toxic drugs whose adverse effects trigger chronic, debilitating illnesses.
Why Has Columbia Expended So Much Effort to Avoid the Conclusion of Patient Harm?
A system that was established to safeguard human subjects by implementing those ethical principles is, instead, geared toward lending the appearance of legitimacy to ethical expediency and corner-cutting at the expense of safety for the subjects of clinical trials and for consumers who are at increased risk of harm from defective drugs and devices.
The most shocking disclosure is that Dr. Biederman’s study testing powerful antipsychotics in PRESCHOOL CHILDREN "was beset by breaches of research protocol,"
Please click here for a presentation on Non-Consensual Research
The efficacy and safety of a new drug that treats a serious and life threatening illness in premature infants will be studied versus sham/placebo in Latin America. The sponsor plans to apply for FDA approval, in addition to local and European registration. There are approved therapies (surfactants) for this illness (Respiratory Distress Syndrome, or RDS) in those countries where this trial is proposed to take place, and surfactants are even used in some of their hospitals. However, surfactants are completely unavailable to infants at many other hospitals, secondary to rationing or economic limitations.
FDA Considers: Use of Placebo-Controls in Life Threatening Diseases: Is the Developing World the Answer? The efficacy and safety of a new drug that treats a serious and life threatening illness in premature infants will be studied versus sham / placebo in Latin America.